Identification |
Name: | Ozagrel |
Synonyms: | Ozagrel [INN];Ozagrelum [Latin];2-Propenoic acid,3-[4-(1H-imidazol-1- ylmethyl)phenyl]-,(2E)-;(E)-p-(Imidazol-1-ylmethyl)cinnamic acid;Ozagrel (E);2-Propenoic acid, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-, (E)-;(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid; |
CAS: | 82571-53-7 |
Molecular Formula: | C13H12N2O2 |
Molecular Weight: | 228.25 |
InChI: | InChI=1/C13H12N2O2/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15/h1-8,10H,9H2,(H,16,17)/b6-5+ |
Molecular Structure: |
|
Properties |
Melting Point: | 223 - 224 |
Flash Point: | 236.8 oC |
Boiling Point: | 468 oC at 760 mmHg |
Density: | 1.17 g/cm3 |
Refractive index: | 1.593 |
Solubility: | Slightly soluble |
Appearance: | white powder |
Specification: |
? Ozagrel (CAS NO.82571-53-7), its Synonyms are Ozagrelum ; (E)-p-(Imidazol-1-ylmethyl)cinnamic acid ; 2-Propenoic acid, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-, (E)- ; Ozagrel sodium base ; Ozagrel sodium .
|
Flash Point: | 236.8 oC |
Storage Temperature: | Store in original container in a cool dark place. |
Usage: | A thromboxane a2 synthesis inhibitor.[. |
Safety Data |
|
|